wfaqfdsvvaadutyycertbyqcc

Global

Jun 19, 2017
Pharmaceutical Executive
Last week’s EFPIA and EU Health Council annual conferences highlighted the growing divisions—and resentments—between industry and governments on drug pricing. Reflector reports.
Jun 02, 2017
With the UK's General Election set for June 8, Leela Barham looks what the competing parties are promising for pharma and healthcare
May 23, 2017
In the hothouse atmosphere of European governments' anxieties over ever more expensive medicines, recent weeks have seen perspiration breaking out on the brows of ministers, officials and drug company executives, writes Reflector.
Apr 24, 2017
The external reference pricing circus has rolled back into town, promising another great European show. The fight-back comes via one of Europe's most obscure bodies, the European Integrated Price Information Database—better known as Euripid.
Apr 10, 2017
Nine months on from the 2016 EFPIA Disclosure Code deadline — requiring all member companies to publish data concerning their transfer-of-value transactions to HCPs — EFPIA's Andrew Powrie-Smith offered an update on media and industry responses.
Mar 06, 2017
The European Commission's latest economic assessment of EU member states does not make for comfortable reading, writes Reflector.
Mar 01, 2017
Leela Barham looks at NICE's new position statement, which seeks to set out more clearly how it works with industry.
Feb 28, 2017
Pharmaceutical Executive
A panel of biopharma executives responsible for the Latin America business discuss investment, market access, and reimbursement issues in this key regional growth market for the life sciences industry.
Feb 21, 2017
Pharmaceutical Executive
Outlining one country’s unique price-setting model for novel drugs—and the resulting pre-launch strategies for manufacturers.
Jan 31, 2017
As the healthcare landscape evolves, pharmaceutical companies are being driven to embrace new, unique partnerships to go beyond the pill, writes Weng Si Ho.
lorem ipsum